Mechanisms of Action

Unlike conventional pharmaceutical interventions that typically target a single receptor, enzyme, or step in a pathological cascade, the application of a living medicinal leech engages at least three distinct but synergistic pathways simultaneously (Baskova, 2004). Understanding these pathways and the manner in which they interact is essential for rational clinical application and for distinguishing evidence-based hirudotherapy from empirical tradition.

These three pathways operate on different timescales, creating a temporally layered therapeutic response. Local effects begin within seconds of leech attachment. Neuroreflexive responses develop over minutes as afferent signals reach spinal and supraspinal processing centers. Systemic effects emerge over hours as SGS components distribute through the circulation. This temporal layering may explain why clinical benefits of a single hirudotherapy session often persist for days to weeks — far longer than the pharmacokinetic half-life of any individual SGS component would predict (Baskova, 2004).

Quantitative Session Parameters

The local mechanism encompasses all direct biochemical and biophysical effects of SGS compounds on the tissue immediately surrounding the bite. Upon biting through the skin, the medicinal leech releases its salivary gland secretion directly into the dermal capillary bed. The SGS contains over 100 identified bioactive molecules (Liu et al., 2019; Babenko et al., 2020), each evolved to serve the leech’s feeding requirements but collectively producing a complex pharmacological intervention at the wound site. Integrated proteomics-transcriptomics studies have cataloged over 200 salivary proteins in six functional categories: analgesic/anti-inflammatory, extracellular matrix degradation, platelet inhibition, anticoagulant, antimicrobial, and other functions (Liu et al., 2019).

2.1. The Wound Microenvironment

The leech contributes to local effects through two additional physical mechanisms beyond secretion delivery. First, the three-jawed bite creates a characteristic Y-shaped wound approximately 2 mm in depth, establishing direct access to the superficial dermal vascular plexus. Second, the muscular pharyngeal pump generates negative pressure at the wound site and in adjacent tissues, actively augmenting blood flow to the feeding area (Baskova, 2004). This mechanical suction effect enhances the distribution of SGS components into surrounding tissue and contributes to local decongestive effects.

2.2. Microcirculation Enhancement

The most immediately observable local effect of leech application is the dramatic increase in blood flow to the treatment area. This results from several concurrent processes operating simultaneously:

2.3. Mast Cell Degranulation Modulation

Mast cells, abundant in the dermis, play a central role in the local inflammatory response. SGS components interact with mast cells through multiple receptor-mediated pathways. The leech-derived tryptase inhibitor (LDTI) specifically inhibits mast cell tryptase, a serine protease that promotes inflammation, fibroblast proliferation, and extracellular matrix remodeling (Sommerhoff et al., 1994). By modulating mast cell degranulation rather than simply suppressing it, the SGS creates a controlled local anti-inflammatory environment without eliminating the protective functions of the innate immune response.

Bdellins and eglins — serine protease inhibitors that target neutrophil elastase, cathepsin G, and plasmin — further modulate the inflammatory cascade downstream of mast cell activation. Eglins inhibit the release of proinflammatory cytokines from activated neutrophils, while bdellins reduce the proteolytic tissue damage that accompanies acute inflammation (Baskova & Zavalova, 2001). Together, these inhibitors produce a local anti-inflammatory effect that is functionally distinct from corticosteroids or NSAIDs: rather than broadly suppressing inflammation, they selectively attenuate the tissue-destructive components while preserving the reparative processes.

2.4. Local Anti-Inflammatory Cascade

The anti-inflammatory effect at the local level involves coordinated suppression of multiple inflammatory mediators through functionally distinct pathways:

• Complement modulation — Carboxypeptidase inhibitors in the SGS regulate the complement-derived anaphylatoxins C3a and C5a, reducing chemotaxis of inflammatory cells to the wound site.
• Neutrophil elastase inhibition — Eglins (eglin C in particular) and guamerin inhibit neutrophil elastase with high specificity, preventing the extracellular matrix degradation and tissue edema that characterize acute inflammation.
• Bradykinin regulation — Carboxypeptidase inhibitors also modulate bradykinin metabolism, influencing local vascular permeability and pain signaling.
• Antimicrobial defense — Destabilase, a multifunctional enzyme with both lysozyme (muramidase) and isopeptidase activities, provides antimicrobial protection at the wound site (Kurdyumov et al., 2015). Additional antimicrobial peptides — theromyzin, theromacin, and peptide B — contribute to wound defense against opportunistic pathogens.

Clinically, the local anti-inflammatory effect manifests as reduction of tissue edema, relief of local pain, and acceleration of wound healing. These properties support the established use of hirudotherapy in surgical conditions (thrombophlebitis, varicose veins, postoperative wound complications, abscesses, furuncles), dental practice, trauma management, and inflammatory joint and skin diseases where leeches are applied directly to the affected area (Baskova, 2004).

2.5. Extracellular Matrix Remodeling

Hyaluronidase occupies a unique position among SGS components. By catalyzing the hydrolysis of hyaluronic acid — a major structural component of the dermal extracellular matrix — it increases tissue permeability and facilitates the interstitial diffusion of all other SGS compounds. Beyond its spreading function, hyaluronidase-mediated matrix remodeling may contribute to the resolution of fibrotic tissue changes associated with chronic inflammation. The degradation of hyaluronic acid generates oligosaccharide fragments that themselves possess immunomodulatory properties, potentially contributing to the anti-inflammatory milieu at the application site.

The tissue penetration facilitated by hyaluronidase is pharmacologically significant for OA applications. Experimental data on topical diclofenac gel applied to knees with joint effusions demonstrated drug detection in deep periarticular tissues and body compartments. With the additive effect of hyaluronidase as a spreading factor, it is highly probable that the antiphlogistic substances in leech SGS penetrate deep enough to exert significant effects on periarticular myofascial structures and perhaps even on intra-articular structures (Michalsen et al. 2007). A recent study confirmed that periarticular myofascial structures play a critical role in the development of chronic joint pain and regional pain syndromes in patients with osteoarthritis.

Collagenase activity has also been identified in leech SGS (Liu et al., 2019), providing an additional pathway for extracellular matrix modification. The combination of hyaluronidase and collagenase activity suggests that the leech has evolved a coordinated approach to tissue penetration that simultaneously serves its feeding requirements and — incidentally — produces therapeutic matrix remodeling effects in the host tissue.

2.6. Complete SGS Compound Categories at the Local Level

2.7. Evidence Base for Local Mechanisms

The local mechanism is supported by the strongest evidence among the three pathways:

• In vitro studies — Individual SGS components have been characterized biochemically and their targets identified at the molecular level. The draft genome of H. medicinalis (Kvist et al., 2020; Babenko et al., 2020) has enabled identification of 15 anticoagulation factors and 17 additional antihemostatic proteins, with integrated proteomics-transcriptomics studies cataloguing over 200 salivary proteins in six functional categories (Liu et al., 2019).
• Animal models — Leech application produces measurable changes in local blood flow, tissue oxygenation, and wound healing parameters in standardized animal models.
• Clinical observation — Microsurgical flap salvage represents the highest level of clinical evidence for local mechanisms, supported by systematic reviews documenting salvage rates of 65–80% across hundreds of reported cases (Whitaker et al., 2004). Tissue spectrophotometry and laser Doppler flowmetry studies have quantified the magnitude and duration of microcirculatory changes (Rothenberger et al., 2016).
• Pharmacological validation — Multiple SGS-derived compounds have progressed to pharmaceutical development, including three FDA-approved direct thrombin inhibitors (lepirudin, bivalirudin, desirudin) and recombinant destabilase in preclinical development for aged thrombus dissolution (Kurdyumov et al., 2021).

If hirudotherapy were purely a local pharmacological intervention, the site of leech application would matter only insofar as it determines which tissues receive the direct effects of SGS. Yet clinical experience consistently demonstrates that the location of application influences therapeutic outcomes in organs distant from the treatment site. Leeches applied to the precordial region improve anginal symptoms. Leeches applied to the right hypochondrium reduce hepatic congestion. Leeches applied to the mastoid process region lower arterial blood pressure (Baskova, 2004). These observations cannot be explained by local mechanisms alone.

3.1. Dermatomal Organization: The Head Framework

The neuroanatomical foundation for the reflexive pathway rests on the principle of dermatomal organization — the segmental arrangement of sensory innervation established during embryonic development. Each spinal nerve innervates a defined strip of skin (a dermatome) and, through its visceral branches, a corresponding set of internal organs. This dual innervation creates bidirectional neural pathways between the body surface and the viscera.

In 1889, Grigory Zakharyin was the first to document that diseases of internal organs produce referred pain and altered sensitivity in specific cutaneous areas. He observed that during or following an anginal episode, touching the patient’s skin at certain body areas produced pain. Henry Head (1898) subsequently mapped these zones of cutaneous hyperalgesia systematically, establishing the association between visceral disease and altered skin sensitivity in corresponding dermatomes.

The Head zones are now understood through the lens of modern neuroanatomy as a manifestation of viscerosomatic convergence — the convergence of visceral and somatic afferent neurons at common spinal cord segments. Smolin (1982) and Cervero & Tattersall (1985) demonstrated that visceral and cutaneous afferent fibers converge onto the same dorsal horn neurons. Because the cerebral cortex receives far more somatosensory than visceral input, it misinterprets visceral nociceptive signals arriving through shared spinal pathways as originating from the corresponding dermatome. This "convergence-projection" mechanism explains referred pain and, critically, also explains why stimulation of the appropriate dermatome can modulate visceral function.

The convergence operates at multiple levels of the neuraxis. Cervero & Connell (1983) showed that visceral-cutaneous signal interaction begins at the level of primary sensory neurons in the dorsal root ganglia. The interaction extends through the dorsal horn of the spinal cord, where somatic afferents may synapse onto visceroreceptor neurons in the lateral horns, and continues through the brainstem (reticular formation), thalamus, and cortex (Nozdrachev, 1983). The extensive vertical integration of this convergence ensures that cutaneous stimulation can produce both spinal and supraspinal effects on visceral function.

3.2. Segmental Innervation of Major Organs

The following table summarizes the segmental innervation of major internal organs, providing the neuroanatomical basis for application site selection in hirudotherapy (adapted from Table 19, Baskova, 2004):

Clinical significance: The heart receives sympathetic innervation from segments T1 through T5 and parasympathetic innervation from C2 through C5. The Head zones for cardiac disease therefore span dermatomes C3 through T5 — precisely the cutaneous areas where patients with angina pectoris report referred pain along the medial surface of the arm and forearm, in the precordial region, and in the interscapular area. Head documented that in angina pectoris, generalized zones of hyperalgesia appeared in dermatomes C3–C4 and T1–T5, sometimes extending bilaterally (Head, 1898).

3.3. Objective Detection of Dermatomal Changes: Biophysical Methods

The viscerocutaneous reflex produces not only subjective hyperalgesia but also objectively measurable changes in the biophysical properties of the skin within the corresponding dermatomes. These include alterations in vasomotor activity, sweat gland function, skin temperature, electrical potential and capacitance, and resistance to electric current (Borodulin, 1963; Voll, 1973; Warren, 1976; Eory, 1984).

Isakhanyan (1969) studied zones of increased pain sensitivity and temperature asymmetry in 33 patients with chronic CAD. Skin temperature was measured using a TSM-2 electric thermometer in a controlled environment (room temperature 20–23 °C), with the patient supine and the thorax exposed, allowing 15–20 seconds for stabilization at each measurement site. Zones of altered sensitivity were identified in 7 of 33 patients: cutaneous thermoasymmetry in 4 patients, prolonged pinprick adaptation time (20–30 seconds) in 1 patient, and both changes in 2 additional patients. The relatively low detection rate was attributed to the chronic, stable disease course and the frequent absence of acute anginal episodes at the time of examination.

These biophysical methods confirm that Head zones correspond to objectively measurable physiological alterations in the dermatomal skin, consistent with contemporary understanding of central sensitization: visceral nociceptive input dynamically alters the excitability of dorsal horn neurons, producing transient and spatially variable changes in cutaneous sensitivity within the corresponding dermatomes (Woolf, 2011).

3.4. Gate Control Theory and Pain Modulation

The gate control theory of pain, proposed by Melzack & Wall in their landmark 1965 paper in Science, provides a foundational framework for understanding how the leech bite — a peripheral cutaneous stimulus — can modulate pain perception. The theory proposes that a neural mechanism in the dorsal horn acts as a "gate" modulating nociceptive transmission:

• Large-diameter myelinated A-beta fibers (conveying touch, pressure, vibration): activity excites inhibitory interneurons in the substantia gelatinosa (lamina II), which suppress second-order transmission neurons — effectively "closing the gate".
• Small-diameter C fibers and A-delta fibers (conveying nociceptive signals): activity inhibits the inhibitory interneurons — "opening the gate" and facilitating pain transmission.

When the leech bites, it simultaneously activates both mechanoreceptors (via mechanical pressure of the three-jawed bite) and nociceptors (via tissue damage). The sustained mechanical stimulation of A-beta fibers during feeding — which lasts 20 to 45 minutes — activates the gate control mechanism, reducing nociceptive transmission from the same and adjacent dermatomes. This is the same principle exploited by transcutaneous electrical nerve stimulation (TENS) and the intuitive human behavior of rubbing an injured area (Sluka & Walsh, 2003).

However, gate control theory alone cannot fully account for the analgesic effects of hirudotherapy. The theory predicts analgesia lasting only as long as the large-fiber stimulation continues. Clinical pain relief from leech therapy persists for hours to days. Additional mechanisms must therefore be involved.

3.5. Descending Pain Modulation: PAG-RVM Pathway

Beyond the spinal gate, the CNS has a powerful descending pain modulatory system originating in the brainstem and projecting to the spinal cord dorsal horn. Two principal structures are involved:

3.6. Conditioned Pain Modulation (CPM / DNIC)

Peripheral noxious stimulation — including the sustained nociceptive input from a leech bite — can activate the descending modulatory system through the phenomenon known as diffuse noxious inhibitory controls (DNIC), now more commonly termed conditioned pain modulation (CPM). First described by Le Bars et al. (1979), DNIC represents a "pain-inhibits-pain" mechanism in which noxious stimulation at one body site inhibits second-order wide dynamic range (WDR) neurons at distant spinal segments.

The neurochemical mediators of DNIC include norepinephrine (acting through spinal alpha-2 adrenoreceptors), serotonin (acting through 5-HT receptors in the dorsal horn), and endogenous opioids (acting through mu and delta receptors in the PAG and RVM). The involvement of multiple neurotransmitter systems suggests that activation by the leech bite produces a robust and sustained antinociceptive response (Yarnitsky, 2010).

This mechanism provides a neurophysiological explanation for the observation that leech application at one body site can reduce pain perception at distant sites. The sustained nociceptive input from the bite wound — which continues for hours during post-detachment bleeding — may produce prolonged activation of the descending inhibitory system.

3.7. Additional Analgesic Mechanisms

3.8. Integrated Temporal Model of Analgesia

The multiple analgesic mechanisms can be organized into a temporal sequence that explains the characteristic clinical pattern of pain relief following hirudotherapy:

This multi-layered temporal model explains why clinical pain relief from hirudotherapy often exceeds what would be predicted by any single mechanism in isolation.

3.9. Somatoautonomic Reflexes — The Core Therapeutic Mechanism

The most therapeutically significant aspect of the neuroreflexive pathway is not pain modulation per se, but the activation of somatoautonomic reflexes — neural pathways through which cutaneous stimulation modulates autonomic nervous system activity and, thereby, visceral organ function. Systematically characterized by Sato & Schmidt beginning in 1966, the somatoautonomic reflex follows a defined arc (Sato et al., 1997; Li et al., 2016):

1. Stimulation of cutaneous mechanoreceptors and nociceptors activates somatic afferent neurons (cell bodies in dorsal root ganglia)
2. Afferent signals transmitted to spinal cord, processed and relayed to autonomic efferent neurons
3. Postganglionic fibers terminate on adrenergic or cholinergic effector cells in target organs
4. Sympathetic or parasympathetic responses produced in target organ

The critical feature is segmental specificity. Cutaneous stimulation at a given dermatomal level preferentially activates autonomic pathways innervating organs sharing the same spinal cord segments. Somatic afferents entering the spinal cord switch onto visceroreceptor neurons in the lateral horns (intermediolateral column, T1–L2), giving rise to preganglionic sympathetic fibers. This means stimulation of dermatomes T1–T5 preferentially modulates cardiac autonomic function, T7–T11 preferentially modulates hepatobiliary function, and so on (Sudakov et al., 1986).

The postganglionic fibers terminate on both adrenergic and cholinergic neurons, meaning cutaneous dermatomal stimulation can produce either sympathetic or parasympathetic effects: vasospasm or vasodilation, slowing or acceleration of intestinal peristalsis, modulation of glandular secretion (Sudakov et al., 1986). The direction and magnitude depend on stimulus intensity, duration, modality, and the baseline autonomic tone of the target organ.

Li et al. (2020) demonstrated two key organizational principles directly relevant to hirudotherapy practice:

• Acupoint selectivity: specific skin locations activate distinct autonomic pathways, validating the practice of selecting application sites based on their segmental relationship to the target organ.
• Intensity dependence: the strength of the cutaneous stimulus determines which autonomic pathways are activated. The leech bite, producing sustained moderate-intensity nociceptive and mechanical stimulation over 20–45 minutes of feeding followed by hours of wound bleeding, represents a stimulus profile well suited to sustained autonomic modulation.

3.10. The Cutaneous-Visceral Reflex in Practice: Clinical Demonstration

A concrete clinical example illustrates the principle. When leeches are applied to the precordial region for angina pectoris, the bite stimulates cutaneous afferents in dermatomes T1 through T5 — the same spinal segments providing sympathetic innervation to the heart. Isakhanyan (1969) demonstrated this principle using thermal stimulation of the precordial zone in patients with coronary artery disease:

These observations establish that the clinical zones traditionally used in hirudotherapy are designated application zones — extensive cutaneous areas within the dermatomes that share segmental innervation with the target organ. The therapeutic stimulus from any point within this dermatomal zone is mediated via the somatovisceral reflex pathway. This is the same principle that underlies all forms of cutaneous reflex therapy: TENS, thermotherapy, mustard plasters, topical counter-irritants, and procaine blocks (Baskova, 2004).

3.11. Comparison with Other Cutaneous Therapies

Hirudotherapy is not the only therapeutic modality that exploits cutaneous-visceral reflexes, but it is unique in combining neuroreflexive stimulation with simultaneous pharmacological delivery. The following comparison clarifies its distinctive features:

Neurophysiological research has demonstrated that acupuncture effects are mediated by the nervous system — specifically, by cutaneous-visceral reflexes operating through segmental innervation pathways (Peng, 1986). The meridians defined in traditional Chinese medicine correspond anatomically to the topography of peripheral nerve trunks and neurovascular bundles (Dung, 1984). The designated application sites used in acupuncture are located within the same dermatomes as the broader Head zones — the coincidence is not accidental, because both reflect the underlying segmental innervation (Pishel et al., 1995).

The key distinction between acupuncture and hirudotherapy as reflex therapy methods lies in stimulus characteristics: acupuncture delivers a point-based mechanical stimulus from a metal needle at precise anatomical locations, while hirudotherapy delivers a broader stimulus from a biologically active zone. A course of hirudotherapy typically requires up to 50 or more leeches; the cutaneous zones must be territorially sufficient to accommodate this number, a requirement better served by dermatomal zones than by individual acupuncture points.

3.12. Application Site Selection: Dermatomal Rationale

The neuroanatomical evidence establishes that the traditional practice of applying leeches to specific body regions is not an empirical survival from pre-scientific medicine but a rational therapeutic strategy grounded in the segmental organization of the nervous system. Application site selection follows a clear algorithm:

1. Identify the target organ and its spinal segmental innervation (see segmental innervation table above).
2. Map the corresponding dermatomes on the body surface.
3. Apply leeches within these dermatomes, selecting areas that are accessible, well-vascularized, and distant from major vessels and nerves.

This reframing has practical significance: relocating leeches within the appropriate dermatomal zone does not fundamentally alter the reflexive mechanism of action. Whether leeches are placed at specific acupuncture points or distributed across the broader reflex zone, the afferent signals reach the same spinal cord segments and activate the same somatoautonomic reflex arc. The apparent coincidence between traditional hirudotherapy zones, Head zones, and acupuncture meridian distributions reflects the same underlying dermatomal neuroanatomy (Baskova, 2004).

The third pathway of therapeutic action involves the entry of SGS bioactive compounds into the lymphatic and venous circulation, where they produce effects at sites distant from the application point. Two pathways of systemic distribution have been proposed (Baskova, 2004):

4.1. Evidence of Prolonged Local SGS Activity

The prolonged local bleeding that follows leech detachment — typically lasting 24 to 48 hours — provides direct evidence that anticoagulant components of the SGS remain bioactive in the wound for an extended period. Thromboelastographic analysis of blood collected from bite wounds during the first 45 to 60 minutes after detachment confirmed that SGS temporarily blocks hemostasis at the wound site (Isakhanyan et al., 1989; Isakhanyan, 1991) — substantially longer than the 15 to 20 minutes estimated by earlier coagulation studies. The longer SGS components remain in the wound area, the greater the opportunity for absorption into blood and lymphatic circulation.

The lymphatic system plays a particularly important role. Lymphatic microvessels draining the dermis continuously absorb interstitial fluid and return it to the venous circulation. Under normal physiological conditions, 60% of plasma volume and 45% of plasma proteins transit from the microcirculation into the interstitial space daily, carrying protein-bound metabolites into the lymphatic system before returning to the bloodstream (Chernukh & Frolov, 1982). SGS components deposited in the dermal interstitium would be subject to this same lymphatic clearance mechanism. Moreover, hyaluronidase — by increasing tissue permeability through ECM degradation — facilitates the interstitial diffusion and subsequent lymphatic absorption of other SGS compounds.

4.2. Hirudin Pharmacokinetics (Reference Data)

The pharmacokinetics of recombinant hirudin have been studied extensively in the context of drug development, providing a framework for understanding the systemic anticoagulant effects. These parameters, derived from purified recombinant protein, provide only an approximation of native hirudin behavior released into a bite wound:

4.3. Systemic Anticoagulant Effects

Clinical observations support the occurrence of systemic anticoagulant effects. Isakhanyan (1991) reported that in patients with circulatory decompensation, venous blood that had clotted in the syringe before hirudotherapy showed a tendency toward hypocoagulation following leech application. The anticoagulant effect was observed regardless of the site of leech application — precordial area, right hypochondrium, or mastoid process — suggesting a systemic rather than purely local mechanism (Baskova, 2004). Platelet aggregation inhibition has also been documented as a systemic effect, independent of cutaneous application site, potentially mediated by calin, saratin, and decorsin.

Several clinical observations illustrate the phenomenon: a patient experienced profuse bleeding for 12 hours after leech detachment, prompting a surgeon to apply metal staples to the wounds; blood then seeped from the staple wounds as well, and hemostasis was ultimately achieved only with a tight pressure dressing applied over the entire operative field (Baskova, 2004). In five cases, blood flowing from bite wounds was collected into polypropylene tubes for 45–60 minutes after detachment; thromboelastographic analysis confirmed that SGS blocks hemostasis for this period (Isakhanyan et al., 1989).

4.4. Systemic Anti-Inflammatory Effects

Beyond anticoagulation, several SGS components have the potential to produce systemic anti-inflammatory effects upon entering the circulation:

• Complement modulation — SGS inhibitors of complement-derived anaphylatoxins and carboxypeptidases could modulate the complement cascade at distant sites, consistent with the convergent model of coagulation recognizing that coagulation and innate immune activation are interconnected (Yong & Toh, 2023).
• Cytokine suppression — Bdellins and eglins, through neutrophil serine protease inhibition, reduce release of proinflammatory cytokines (IL-1β, IL-6, TNF-α) from activated neutrophils and macrophages. At sufficient systemic concentrations, these could attenuate the systemic inflammatory response.
• Immune modulation — Clinical observations have documented changes in immune parameters: modulation of lymphocyte subpopulations and immunoglobulin levels. The presence of lectins, ficolins, and CRISP proteins in the secretion (Babenko et al., 2020) suggests multiple pathways of immune interaction.

4.5. Blood Rheology Changes

Hirudotherapy produces measurable changes in blood rheological parameters documented across multiple clinical studies:

• Decreased blood viscosity — Attributed to anticoagulant and fibrinolytic effects of absorbed SGS, as well as mechanical depletion of blood volume through ingestion (5–15 mL per leech) and post-detachment bleeding (up to 50 mL per wound).
• Reduced erythrocyte aggregation — Potentially mediated by calin and other platelet/cell adhesion inhibitors.
• Improved erythrocyte deformability — Possibly resulting from reduced fibrinogen levels and altered plasma protein composition.

These rheological changes improve microcirculatory flow characteristics and may contribute to clinical benefits in conditions characterized by hyperviscosity: chronic venous insufficiency, polycythemia, and microvascular complications of diabetes.

In a cohort of 23 patients receiving a single leech treatment in the lumbar region, reduced viscoelasticity and aggregation tendency of the blood were observed four weeks after treatment, while hematocrit and plasma viscosity values remained unchanged. Given the short plasma half-life of hirudin (~60 minutes IV, ~120 minutes SC), the authors proposed that differential stimulation of erythropoiesis might be responsible for this long-term modulation of hemorheological parameters (Michalsen et al. 2007, citing Kalender et al.).

4.6. Lipid Metabolism Effects — An Intriguing Observation

Multiple investigators have reported stabilization of lipid metabolism following hirudotherapy, regardless of application site. Leeches applied to the mastoid process region, the precordial area, or the right hypochondrium all produced improvements in blood lipid profiles in patients with atherosclerosis (Isakhanyan, 1991; Kovalenko et al., 1998; Azarov et al., 1999). Since lipid metabolism is primarily regulated by the liver, and the liver’s reflex zone encompasses dermatomes T7–T11, the lipid-lowering effect observed with precordial (T1–T5) or mastoid application cannot be attributed to the reflexive pathway alone.

This observation suggests that either the systemic mechanism contributes through absorbed SGS components acting on hepatic or systemic metabolic pathways, or that the reflexive mechanism operates through more complex intersegmental pathways than simple dermatomal correspondence would predict. The question remains open and warrants investigation with modern metabolomics and pharmacokinetic methods.

4.7. Evidence Base for Systemic Mechanisms

• Pharmacological reasoning — All intradermally or subcutaneously administered substances enter the systemic circulation. Recombinant hirudin has nearly 100% bioavailability after subcutaneous injection (Markwardt et al., 1984).
• Clinical observation — Anticoagulant and antiplatelet effects observed regardless of application site, implying systemic distribution.
• Blood marker studies — Multiple investigators have documented changes in coagulation parameters, platelet aggregation, blood viscosity, and lipid profiles following hirudotherapy.
• Temporal profile — Some therapeutic effects emerge over hours and persist for days, consistent with the pharmacokinetic time course of absorbed and distributed SGS components.

A critical research priority is the direct measurement of SGS components (particularly hirudin, destabilase, and eglins) in the blood of patients undergoing hirudotherapy, using modern proteomic or immunoassay methods. Such studies would definitively establish the systemic pathway and provide the pharmacokinetic basis for rational dosing.

4.8. Negative Correlations: What Does Not Predict Outcome

Two large studies on leech therapy in knee OA provided sub-analyses that tested whether certain baseline parameters predicted treatment response (Michalsen et al. 2007). The results were consistently negative:

• Connective tissue zones: No correlation between the extent of local connective tissue zones (Bindegewebszonen) and clinical efficacy. Some practitioners postulate that leech therapy is especially effective in patients with pronounced connective tissue changes, but this was not supported by the data.
• Hematocrit and blood volume: No correlation between initial hematocrit levels, the volume of blood extracted by the leech, or BMI (used as approximate constitutional parameters) and treatment outcome.
• Lymphedema: Clinical efficacy was demonstrated even in patients without palpable tissue abnormalities or lymphedema, suggesting that stimulation of lymph flow, while potentially relevant in varicosis, is of limited relevance to the pain-relieving mechanism.

These negative findings are clinically significant: they indicate that the multi-target mechanism of hirudotherapy operates independently of the patient’s constitutional type or humoral parameters. The Pischinger basic regulation model, which focuses on connective tissue protein storage and ground substance regulation rather than cellular processes, provides a theoretical framework for this observation, though its relevance to the pain-relieving effect remains speculative.

The three mechanisms of hirudotherapy do not merely coexist — they interact synergistically in ways that may amplify the therapeutic effect beyond what any single mechanism would achieve alone. Understanding these interactions is critical for rational clinical application.

5.1. Temporal Sequence of the Three Pathways

5.2. Synergistic Interactions Between Pathways

5.3. Why Hirudotherapy May Exceed the Sum of Its Parts

The multi-mechanism nature of hirudotherapy distinguishes it from single-mechanism pharmaceutical interventions. A conventional anticoagulant (e.g., warfarin, heparin, or a DOAC) targets one step in the coagulation cascade. Hirudotherapy simultaneously engages local anticoagulation at multiple cascade steps, neuroreflexive modulation of organ function, and systemic anti-inflammatory and rheological effects.

The analogy to combination pharmacotherapy is instructive. In cardiovascular medicine, combination regimens (anticoagulant plus antiplatelet plus antihypertensive plus lipid-lowering agent) are routinely used because the pathology involves multiple interconnected mechanisms. Hirudotherapy, by delivering over 100 bioactive compounds through three distinct pathways, may function as an inherent combination therapy — albeit one whose "dosing" is difficult to standardize and whose pharmacokinetics are incompletely characterized.

The three-mechanism framework provides a rational basis for selecting the site, number, and frequency of leech application in different clinical contexts. The primary mechanism driving the therapeutic rationale determines the application strategy:

6.1. Clinical Application Site Reference

6.2. Cross-References to Clinical Applications

The mechanisms described on this page provide the physiological foundation for clinical applications across multiple specialties:

• Cardiovascular conditions — Local anticoagulation, reflexive modulation of cardiac autonomic tone, and systemic anticoagulant/rheological effects.
• Surgical applications — Primarily local mechanism: microcirculation enhancement, venous decompression, wound healing acceleration.
• Neurological conditions — Reflexive mechanism through dermatomal stimulation, with systemic anti-inflammatory support.
• Gynecological applications — Reflexive mechanism via lower abdominal/pelvic dermatomal application (T12–L3).
• Inflammatory and rheumatic conditions — Combined local anti-inflammatory effect (when applied to affected joints) with systemic anti-inflammatory and analgesic mechanisms.

The three-mechanism framework identifies several high-priority research questions that would advance hirudotherapy from a mechanism-plausible to a mechanism-proven therapeutic modality: